Thanks for the reddit article. Found that very interesting and educational. Since it is the same company that is now HGEN, and I will take your word for it that much of the top management is the same, it is very realistic that they might be able to pull off another big squeeze since they now know how, from experience. I am always excited when someone can find a way to shove it to the shorts in the shorts.
Also here is something that we have agreed to disagree on. I haven’t mentioned it lately because you deserve to be able to preserve your hopium on the subject.
“The subject of lenzilumab restoring the immune response system is developing in our trial data. I think it is hugely important, and will become even more so.
But, the covid re-infection rate in lenz patients is also something I have long thought is hugely important, and I don't see any data on that yet, after all this time.”
IMO, you will never see data on a covid re-infection rate in Lenz patients. Lenz does not directly affect the covid virus in anyway. It does not create or support antibodies against covid or any other virus.
Also, Lenz does not “restore” the immune system, it tamps it down. That borders on being the opposite of restoring, although you might say it helps to restore the balance of an overactive immune system.
That being said, I don’t want to destroy your hope about the company or the drug but I only want to provide the other side of what I consider mis-information (not disinformation, because you do truly seem to believe it). 98% of everything you bring to the board is true and useful information and we applaud you for your due diligence and for sharing with us. Your posts are especially beneficial to newbies who come along and want to know what is going on here.